Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -0.59% | 181.44 | 0.7% | $1403.21m | |
| MRK | Merck & Co., Inc. | -0.81% | 92.52 | 0.7% | $1231.41m | |
| PFE | Pfizer Inc. | -0.52% | 51.43 | 0.9% | $1227.75m | |
| LLY | Eli Lilly & Co. | 0.06% | 325.90 | 1.1% | $1136.77m | |
| BMY | Bristol-Myers Squibb Co. | -0.48% | 78.61 | 1.0% | $1131.94m | |
| ABBV | AbbVie, Inc. | -0.05% | 152.48 | 1.9% | $1018.79m | |
| AZN | AstraZeneca Plc | -0.67% | 66.45 | 1.0% | $449.05m | |
| SGEN | Seagen Inc. | -1.61% | 176.45 | 5.7% | $320.77m | |
| GSK | GSK Plc | -0.60% | 43.43 | 0.2% | $295.67m | |
| TPTX | Turning Point Therapeutics, Inc. | 0.00% | 75.17 | 0.0% | $291.93m | |
| MRTX | Mirati Therapeutics, Inc. | 2.70% | 70.00 | 1.6% | $204.79m | |
| SIGA | SIGA Technologies, Inc. | -11.89% | 11.49 | 0.0% | $193.57m | |
| HZNP | Horizon Therapeutics Plc | 0.00% | 85.13 | 5.4% | $182.59m | |
| NVS | Novartis AG | -0.04% | 84.79 | 0.2% | $167.69m | |
| NVO | Novo Nordisk A/S | 0.60% | 112.84 | 0.1% | $148.24m |
Company Profile
Horizon Therapeutics Plc is a biopharmaceutical company, which is engaged in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland.